Astellas, Kyoto University VC Pair Up on Cross-Disciplinary Drug Discovery

May 17, 2021
Astellas Pharma said on May 13 that it has entered into a strategic alliance agreement with Kyoto University Innovation Capital (Kyoto-iCAP), which provides investments and support to companies funded by the university’s researchers, in a bid to fuel the development...read more